F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Bevacizumab

1	Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report 7/20/2020 2:28:50 AM \| Browse: 28 \| Download: 40
2	Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports 4/28/2020 8:04:31 AM \| Browse: 78 \| Download: 59
3	Primary tumor location and survival in colorectal cancer: A retrospective cohort study 4/15/2020 12:00:00 PM \| Browse: 88 \| Download: 94
4	Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy 2/22/2019 4:33:37 AM \| Browse: 267 \| Download: 187
5	Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review 1/16/2019 8:39:45 AM \| Browse: 198 \| Download: 260
6	Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors 12/14/2018 10:51:23 AM \| Browse: 261 \| Download: 119
7	CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer 11/13/2018 8:04:45 AM \| Browse: 320 \| Download: 219
8	Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia 12/20/2016 1:38:00 PM \| Browse: 403 \| Download: 475
9	Role of targeted therapy in metastatic colorectal cancer 9/12/2016 10:43:00 AM \| Browse: 401 \| Download: 426
10	Treatment of diabetic retinopathy: Recent advances and unresolved challenges 8/23/2016 8:55:00 AM \| Browse: 380 \| Download: 468
11	Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer 7/15/2016 3:38:00 PM \| Browse: 498 \| Download: 591
12	Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment 9/30/2015 4:28:00 PM \| Browse: 584 \| Download: 750
13	Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 6/20/2015 5:38:00 PM \| Browse: 623 \| Download: 1158
14	Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab 5/13/2015 10:38:00 AM \| Browse: 479 \| Download: 738
15	Value of bevacizumab in treatment of colorectal cancer: A meta-analysis 4/27/2015 4:29:00 PM \| Browse: 584 \| Download: 876
16	Targeted therapy in first line treatment of RAS wild type colorectal cancer 3/16/2015 6:04:00 PM \| Browse: 555 \| Download: 575
17	FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma 2/11/2015 4:38:00 PM \| Browse: 439 \| Download: 376
18	Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status 11/19/2014 2:49:00 PM \| Browse: 506 \| Download: 443
19	Bevacizumab maintenance in metastatic colorectal cancer: How long? 11/10/2014 12:19:00 PM \| Browse: 477 \| Download: 585
20	Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy 10/20/2014 9:54:00 AM \| Browse: 470 \| Download: 412
21	Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases 9/16/2014 6:10:00 PM \| Browse: 515 \| Download: 425
22	Role of bevacizumab in colorectal cancer growth and its adverse effects: A review 9/15/2014 8:54:00 PM \| Browse: 612 \| Download: 494
23	Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives 9/11/2014 8:40:00 PM \| Browse: 495 \| Download: 903
24	Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012 9/3/2014 11:44:00 AM \| Browse: 561 \| Download: 659
25	Bevacizumab for the management of diabetic macular edema 9/1/2014 3:42:00 PM \| Browse: 543 \| Download: 343
26	Ranibizumab in diabetic macular edema 9/1/2014 2:50:00 PM \| Browse: 463 \| Download: 430
27	Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer 9/1/2014 10:30:00 AM \| Browse: 438 \| Download: 278
28	Targeting receptor tyrosine kinases in gastric cancer 8/28/2014 5:50:00 PM \| Browse: 463 \| Download: 392
29	Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review 8/26/2014 5:16:00 PM \| Browse: 507 \| Download: 350
30	Advances and new perspectives in the treatment of metastatic colon cancer 8/26/2014 4:37:00 PM \| Browse: 513 \| Download: 568
31	Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer 8/26/2014 4:36:00 PM \| Browse: 603 \| Download: 377

Page 1 of 1 ( 31 items )
<<
1
>>

1	Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report 7/20/2020 2:28:50 AM \| Browse: 28 \| Download: 40
2	Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports 4/28/2020 8:04:31 AM \| Browse: 78 \| Download: 59
3	Primary tumor location and survival in colorectal cancer: A retrospective cohort study 4/15/2020 12:00:00 PM \| Browse: 88 \| Download: 94
4	Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy 2/22/2019 4:33:37 AM \| Browse: 267 \| Download: 187
5	Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review 1/16/2019 8:39:45 AM \| Browse: 198 \| Download: 260
6	Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors 12/14/2018 10:51:23 AM \| Browse: 261 \| Download: 119
7	CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer 11/13/2018 8:04:45 AM \| Browse: 320 \| Download: 219
8	Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia 12/20/2016 1:38:00 PM \| Browse: 403 \| Download: 475
9	Role of targeted therapy in metastatic colorectal cancer 9/12/2016 10:43:00 AM \| Browse: 401 \| Download: 426
10	Treatment of diabetic retinopathy: Recent advances and unresolved challenges 8/23/2016 8:55:00 AM \| Browse: 380 \| Download: 468
11	Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer 7/15/2016 3:38:00 PM \| Browse: 498 \| Download: 591
12	Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment 9/30/2015 4:28:00 PM \| Browse: 584 \| Download: 750
13	Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 6/20/2015 5:38:00 PM \| Browse: 623 \| Download: 1158
14	Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab 5/13/2015 10:38:00 AM \| Browse: 479 \| Download: 738
15	Value of bevacizumab in treatment of colorectal cancer: A meta-analysis 4/27/2015 4:29:00 PM \| Browse: 584 \| Download: 876
16	Targeted therapy in first line treatment of RAS wild type colorectal cancer 3/16/2015 6:04:00 PM \| Browse: 555 \| Download: 575
17	FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma 2/11/2015 4:38:00 PM \| Browse: 439 \| Download: 376
18	Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status 11/19/2014 2:49:00 PM \| Browse: 506 \| Download: 443
19	Bevacizumab maintenance in metastatic colorectal cancer: How long? 11/10/2014 12:19:00 PM \| Browse: 477 \| Download: 585
20	Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy 10/20/2014 9:54:00 AM \| Browse: 470 \| Download: 412
21	Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases 9/16/2014 6:10:00 PM \| Browse: 515 \| Download: 425
22	Role of bevacizumab in colorectal cancer growth and its adverse effects: A review 9/15/2014 8:54:00 PM \| Browse: 612 \| Download: 494
23	Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives 9/11/2014 8:40:00 PM \| Browse: 495 \| Download: 903
24	Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012 9/3/2014 11:44:00 AM \| Browse: 561 \| Download: 659
25	Bevacizumab for the management of diabetic macular edema 9/1/2014 3:42:00 PM \| Browse: 543 \| Download: 343
26	Ranibizumab in diabetic macular edema 9/1/2014 2:50:00 PM \| Browse: 463 \| Download: 430
27	Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer 9/1/2014 10:30:00 AM \| Browse: 438 \| Download: 278
28	Targeting receptor tyrosine kinases in gastric cancer 8/28/2014 5:50:00 PM \| Browse: 463 \| Download: 392
29	Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review 8/26/2014 5:16:00 PM \| Browse: 507 \| Download: 350
30	Advances and new perspectives in the treatment of metastatic colon cancer 8/26/2014 4:37:00 PM \| Browse: 513 \| Download: 568
31	Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer 8/26/2014 4:36:00 PM \| Browse: 603 \| Download: 377